Peroxisome proliferator-activated receptor gamma coactivator 1 beta (PPARGC1B) is a coactivator of estrogen receptor (ER)α and ERβ. We previously demonstrated a significant association between a variant of exon 5 of the PPARGC1B gene (+102525 G>A, R265Q) and airway hyperreactivity (AHR). The aims of the study were to evaluate the genetic effects of variants of the PPARGC1B gene on the function of ERs. PPARGC1B +102525G and A gene constructs were generated using PCR and cloned into a pCMV4 promoter vector. A luciferase reporter assay was undertaken in 293T cells cotransfected with one of the PPARGC1B +102525G>A constructs, ERα, and an estrogen response element (ERE) containing a luciferase construct after treatment with 17β-estradiol. According to the luciferase reporter assay, the +102525A allele showed higher ERα activity than the +102525G allele in response to stimulation with 17β-estradiol. In addition, the interaction between ERα and PPARGC1B was evaluated by coprecipitation assay. Human influenza hemagglutinin-tagged PPARGC1B coprecipitated more intensely with ERα in the +102525A than the +102525G construct after 17β estradiol treatment. The variant +102525A allele enhances the activity of ERα to a greater degree than the +102525G allele of PPARGC1B.
Get full access to this article
View all access options for this article.
References
1.
AhmetovII, WilliamsA.G., PopovD.V., LyubaevaE.V., HakimullinaA.M., FedotovskayaO.N., MozhayskayaI.A., VinogradovaO.L., AstratenkovaI.V., MontgomeryH.E., and RogozkinV.A. (2009). The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Hum Genet, 126, 751–761.
2.
AndersenG., WegnerL., YanagisawaK., RoseC.S., LinJ., GlumerC., DrivsholmT., Borch-JohnsenK., JorgensenT., HansenT., SpiegelmanB.M., and PedersenO. (2005). Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity. J Med Genet, 42, 402–407.
3.
AnderssonU., and ScarpullaR.C. (2001). Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol Cell Biol, 21, 3738–3749.
4.
AranyZ., LebrasseurN., MorrisC., SmithE., YangW., MaY., ChinS., and SpiegelmanB.M. (2007). The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab, 5, 35–46.
5.
AraujoL.M., LefortJ., NahoriM.A., DiemS., ZhuR., DyM., Leite-de-MoraesM.C., BachJ.F., VargaftigB.B., and HerbelinA. (2004). Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells. Eur J Immunol, 34, 327–335.
6.
CareyM.A., CardJ.W., BradburyJ.A., MoormanM.P., Haykal-CoatesN., GavettS.H., GravesJ.P., WalkerV.R., FlakeG.P., VoltzJ.W., ZhuD., JacobsE.R., DakhamaA., LarsenG.L., LoaderJ.E., GelfandE.W., GermolecD.R., KorachK.S., and ZeldinD.C. (2007). Spontaneous airway hyperresponsiveness in estrogen receptor-alpha-deficient mice. Am J Respir Crit Care Med, 175, 126–135.
7.
Cavalher-MachadoS.C., de LimaW.T., DamazoA.S., de Frias CarvalhoV., MartinsM.A., e SilvaP.M., and SannomiyaP. (2004). Down-regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin. Eur Respir J, 24, 552–558.
8.
Delgado-ListaJ., Perez-MartinezP., SoliveraJ., Garcia-RiosA., Perez-CaballeroA.I., LovegroveJ.A., DrevonC.A., DefoortC., BlaakE.E., Dembinska-KiecA., RiserusU., Herruzo-GomezE., CamargoA., OrdovasJ.M., RocheH., and Lopez-MirandaJ. (2014). Top single nucleotide polymorphisms affecting carbohydrate metabolism in metabolic syndrome: from the LIPGENE study. J Clin Endocrinol Metab, 99, E384–389.
9.
DijkstraA., HowardT.D., VonkJ.M., AmplefordE.J., LangeL.A., BleeckerE.R., MeyersD.A., and PostmaD.S. (2006). Estrogen receptor 1 polymorphisms are associated with airway hyperresponsiveness and lung function decline, particularly in female subjects with asthma. J Allergy Clin Immunol, 117, 604–611.
10.
EliassonO., ScherzerH.H., and DeGraffA.C.Jr. (1986). Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol, 77, 87–94.
GosensR., ZaagsmaJ., MeursH., and HalaykoA.J. (2006). Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res, 7, 73.
13.
GotoK., ChibaY., SakaiH., and MisawaM. (2008). Glucocorticoids inhibited airway hyperresponsiveness through downregulation of CPI-17 in bronchial smooth muscle. Eur J Pharmacol, 591, 231–236.
14.
GuoY., FanY., ZhangJ., ChangL., LinJ.D., and ChenY.E. (2013). Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta) protein attenuates vascular lesion formation by inhibition of chromatin loading of minichromosome maintenance complex in smooth muscle cells. J Biol Chem, 288, 4625–4636.
15.
HuangT.H., Razmovski-NaumovskiV., KotaB.P., LinD.S., and RoufogalisB.D. (2005). The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases. Respir Res, 6, 102.
16.
KresslerD., SchreiberS.N., KnuttiD., and KralliA. (2002). The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha. J Biol Chem, 277, 13918–13925.
17.
LeeS.H., JangA.S., Woo ParkS., ParkJ.S., KimY.K., UhS.T., KimY.H., ChungI.Y., ParkB.L., ShinH.D., and ParkC.S. (2011). Genetic effect of single-nucleotide polymorphisms in the PPARGC1B gene on airway hyperreactivity in asthmatic patients. Clin Exp Allergy, 41, 1533–1544.
18.
LiY., WedrenS., LiG., CharnT.H., DesaiK.V., BonnardC., CzeneK., HumphreysK., DarabiH., EinarsdottirK., HeikkinenT., AittomakiK., BlomqvistC., ChiaK.S., NevanlinnaH., HallP., LiuE.T., and LiuJ. (2011). Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. Breast Cancer Res, 13, R10.
19.
LinJ., PuigserverP., DonovanJ., TarrP., and SpiegelmanB.M. (2002). Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem, 277, 1645–1648.
20.
LingC., WegnerL., AndersenG., AlmgrenP., HansenT., PedersenO., GroopL., VaagA., and PoulsenP. (2007). Impact of the peroxisome proliferator activated receptor-gamma coactivator-1beta (PGC-1beta) Ala203Pro polymorphism on in vivo metabolism, PGC-1beta expression and fibre type composition in human skeletal muscle. Diabetologia, 50, 1615–1620.
21.
MakJ.C., and BarnesP.J. (1990). Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am Rev Respir Dis, 141, 1559–1568.
22.
MangelsdorfD.J., ThummelC., BeatoM., HerrlichP., SchutzG., UmesonoK., BlumbergB., KastnerP., MarkM., ChambonP., and EvansR.M. (1995). The nuclear receptor superfamily: the second decade. Cell, 83, 835–839.
23.
MatsubaraS., SwaseyC.H., LoaderJ.E., DakhamaA., JoethamA., OhnishiH., BalhornA., MiyaharaN., TakedaK., and GelfandE.W. (2008). Estrogen determines sex differences in airway responsiveness after allergen exposure. Am J Respir Cell Mol Biol, 38, 501–508.
24.
MurphyV.E., CliftonV.L., and GibsonP.G. (2006). Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax, 61, 169–176.
25.
OguzulgenI.K., TurktasH., and ErbasD. (2002). Airway inflammation in premenstrual asthma. J Asthma, 39, 517–522.
26.
OhS.H., ParkS.M., LeeY.H., ChaJ.Y., LeeJ.Y., ShinE.K., ParkJ.S., ParkB.L., ShinH.D., and ParkC.S. (2009a). Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms with the development of asthma. Respir Med, 103, 1020–1024.
27.
OhS.H., ParkS.M., ParkJ.S., JangA.S., LeeY.M., UhS.T., KimY.H., ChoiI.S., KimM.K., ParkB.L., ShinH.D., and ParkC.S. (2009b). Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics. Allergy Asthma Immunol Res, 1, 30–35.
28.
PangJ.J., XuX.B., LiH.F., ZhangX.Y., ZhengT.Z., and QuS.Y. (2002). Inhibition of beta-estradiol on trachea smooth muscle contraction in vitro and in vivo. Acta Pharmacol Sin, 23, 273–277.
29.
ParkK.S., ShinH.D., ParkB.L., CheongH.S., ChoY.M., LeeH.K., LeeJ.Y., LeeJ.K., KimH.T., ParkC.S., HanB.G., KimmK., and OhB. (2006). Putative association of peroxisome proliferator-activated receptor gamma co-activator 1beta (PPARGC1B) polymorphism with Type 2 diabetes mellitus. Diabet Med, 23, 635–642.
30.
PattenI.S., and AranyZ. (2012). PGC-1 coactivators in the cardiovascular system. Trends Endocrinol Metab, 23, 90–97.
31.
PostmaD.S., BleeckerE.R., AmelungP.J., HolroydK.J., XuJ., PanhuysenC.I., MeyersD.A., and LevittR.C. (1995). Genetic susceptibility to asthma—bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med, 333, 894–900.
32.
RahmanI., and MacNeeW (1998). Role of transcription factors in inflammatory lung diseases. Thorax, 53, 601–612.
33.
RoffelA.F., ElzingaC.R., Van AmsterdamR.G., De ZeeuwR.A., and ZaagsmaJ. (1988). Muscarinic M2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function. Eur J Pharmacol, 153, 73–82.
34.
RomieuI., FabreA., FournierA., KauffmannF., VarrasoR., MesrineS., LeynaertB., and Clavel-ChapelonF. (2010). Postmenopausal hormone therapy and asthma onset in the E3N cohort. Thorax, 65, 292–297.
35.
RothM., and BlackJ.L. (2006). Transcription factors in asthma: are transcription factors a new target for asthma therapy?. Curr Drug Targets, 7, 589–595.
36.
SperoffL., and FritzM.A. (2004). Clinical Gynecologic Endocrinology and Infertility, 7th ed. (Lippincott, Williams, and Wilkins, Baltimore, MD).
37.
St-PierreJ., LinJ., KraussS., TarrP.T., YangR., NewgardC.B., and SpiegelmanB.M. (2003). Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem, 278, 26597–26603.
38.
StrachanD.P., ButlandB.K., and AndersonH.R. (1996). Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ, 312, 1195–1199.
39.
TakedaK., OkamotoM., de LangheS., DillE., ArmstrongM., ReisdorfN., IrwinD., KosterM., WilderJ., StenmarkK.R., WestJ., KlemmD., GelfandE.W., Nozik-GrayckE., and MajkaS.M. (2009). Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease. Anat Rec (Hoboken), 292, 1045–1061.
40.
TerzanoC., MoranoS., CeccarelliD., ContiV., PaoneG., PetroianniA., GrazianiE., CarnovaleA., FallarinoM., GattiA., MandosiE., and LenziA. (2009). Effect of insulin on airway responsiveness in patients with type 2 diabetes mellitus: a cohort study. J Asthma, 46, 703–707.
41.
TownsendE.A., SathishV., ThompsonM.A., PabelickC.M., and PrakashY.S. (2012). Estrogen effects on human airway smooth muscle involve cAMP and protein kinase A. Am J Physiol Lung Cell Mol Physiol, 303, L923–L928.
42.
TroisiR.J., SpeizerF.E., WillettW.C., TrichopoulosD., and RosnerB. (1995). Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am J Respir Crit Care Med, 152, 1183–1188.
43.
VillaM.P., BernardiF., BurnacciniM., TuraA., MartelliM., MazzantiL., BergamaschiR., and CacciariE. (1990). Bronchial reactivity and sex hormone: study in a Turner's population. Pediatr Pulmonol, 9, 199–205.
44.
VriezeA., PostmaD.S., and KerstjensH.A. (2003). Perimenstrual asthma: a syndrome without known cause or cure. J Allergy Clin Immunol, 112, 271–282.
45.
WheeldonN.M., NewnhamD.M., CoutieW.J., PetersJ.A., McDevittD.G., and LipworthB.J. (1994). Influence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle. Br J Clin Pharmacol, 37, 583–588.
46.
WirtenbergerM., TchatchouS., HemminkiK., SchmutzhardJ., SutterC., SchmutzlerR.K., MeindlA., WappenschmidtB., KiechleM., ArnoldN., WeberB.H., NiederacherD., BartramC.R., and BurwinkelB. (2006). Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. Carcinogenesis, 27, 2201–2208.
47.
WjstM., and DoldS. (1997). Is asthma an endocrine disease?. Pediatr Allergy Immunol, 8, 200–204.
48.
WoerlyG., HondaK., LoyensM., PapinJ.P., AuwerxJ., StaelsB., CapronM., and DombrowiczD. (2003). Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J Exp Med, 198, 411–421.
49.
XuJ., MeyersD.A., OberC., BlumenthalM.N., MellenB., BarnesK.C., KingR.A., LesterL.A., HowardT.D., SolwayJ., LangefeldC.D., BeatyT.H., RichS.S., BleeckerE.R., and CoxN.J. (2001). Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: collaborative study on the genetics of asthma. Am J Hum Genet, 68, 1437–1446.
50.
ZhaoX.J., McKerrG., DongZ., HigginsC.A., CarsonJ., YangZ.Q., and HanniganB.M. (2001). Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax, 56, 205–211.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
